Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Nationwide surveillance of the antimicrobial susceptibility of Chlamydia trachomatis from male urethritis in Japan.

Takahashi S, Hamasuna R, Yasuda M, Ishikawa K, Hayami H, Uehara S, Yamamoto S, Minamitani S, Kadota J, Iwata S, Kaku M, Watanabe A, Sato J, Hanaki H, Masumori N, Kiyota H, Egawa S, Tanaka K, Arakawa S, Fujisawa M, Kumon H, Wada K, Kobayashi K, Matsubara A, Matsumoto T, Eto M, Tatsugami K, Kuroiwa K, Ito K, Hosobe T, Hirayama H, Narita H, Yamaguchi T, Ito S, Sumii T, Kawai S, Kanokogi M, Kawano H, Chokyu H, Uno S, Monden K, Kaji S, Kawahara M, Takayama K, Ito M, Yoshioka M, Kano M, Konishi T, Kadena H, Nishi S, Nishimura H, Yamauchi T, Maeda S, Horie M, Ihara H, Matsumura M, Shirane T, Takeyama K, Akiyama K, Takahashi K, Ikuyama T, Inatomi H, Yoh M.

J Infect Chemother. 2016 Sep;22(9):581-6. doi: 10.1016/j.jiac.2016.06.010. Epub 2016 Jul 21.

PMID:
27452428
2.

Japanese nationwide surveillance in 2011 of antibacterial susceptibility patterns of clinical isolates from complicated urinary tract infection cases.

Ishikawa K, Hamasuna R, Uehara S, Yasuda M, Yamamoto S, Hayami H, Takahashi S, Matsumoto T, Minamitani S, Kadota J, Iwata S, Kaku M, Watanabe A, Sunakawa K, Sato J, Hanaki H, Tsukamoto T, Kiyota H, Egawa S, Deguchi T, Matsumoto M, Tanaka K, Arakawa S, Fujisawa M, Kumon H, Kobayashi K, Matsubara A, Wakeda H, Amemoto Y, Onodera S, Goto H, Komeda H, Yamashita M, Takenaka T, Fujimoto Y, Tsugawa M, Takahashi Y, Maeda H, Onishi H, Ishitoya S, Nishimura K, Mitsumori K, Ito T, Togo Y, Nakamura I, Ito N, Kanamaru S, Hirose T, Muranaka T, Yamada D, Ishihara S, Oka H, Inatomi H, Matsui T, Kobuke M, Kunishima Y, Kimura T, Ichikawa T, Kagara I, Matsukawa M, Takahashi K, Mita K, Kato M, Okumura K, Kawanishi H, Hashimura T, Aoyama T, Shigeta M, Koda S, Taguchi K, Matsuda Y.

J Infect Chemother. 2015 Sep;21(9):623-33. doi: 10.1016/j.jiac.2015.05.014. Epub 2015 Jun 9.

PMID:
26166322
3.

SLCO1B1, SLCO2B1, and SLCO1B3 polymorphisms and susceptibility to bladder cancer risk.

Bui HT, Fujimoto N, Kubo T, Inatomi H, Matsumoto T.

Cancer Invest. 2014 Jul;32(6):256-61. doi: 10.3109/07357907.2014.907421. Epub 2014 Apr 24.

PMID:
24762081
4.

Polymorphisms of the androgen transporting gene SLCO2B1 may influence the castration resistance of prostate cancer and the racial differences in response to androgen deprivation.

Fujimoto N, Kubo T, Inatomi H, Bui HT, Shiota M, Sho T, Matsumoto T.

Prostate Cancer Prostatic Dis. 2013 Dec;16(4):336-40. doi: 10.1038/pcan.2013.23. Epub 2013 Jul 30.

PMID:
23896625
5.

Nationwide surveillance of bacterial pathogens from patients with acute uncomplicated cystitis conducted by the Japanese surveillance committee during 2009 and 2010: antimicrobial susceptibility of Escherichia coli and Staphylococcus saprophyticus.

Hayami H, Takahashi S, Ishikawa K, Yasuda M, Yamamoto S, Uehara S, Hamasuna R, Matsumoto T, Minamitani S, Watanabe A, Iwamoto A, Totsuka K, Kadota J, Sunakawa K, Sato J, Hanaki H, Tsukamoto T, Kiyota H, Egawa S, Tanaka K, Arakawa S, Fujisawa M, Kumon H, Kobayashi K, Matsubara A, Naito S, Tatsugami K, Yamaguchi T, Ito S, Kanokogi M, Narita H, Kawano H, Hosobe T, Takayama K, Sumii T, Fujii A, Sato T, Yamauchi T, Izumitani M, Chokyu H, Ihara H, Akiyama K, Yoshioka M, Uno S, Monden K, Kano M, Kaji S, Kawai S, Ito K, Inatomi H, Nishimura H, Ikuyama T, Nishi S, Takahashi K, Kawano Y, Ishihara S, Tsuneyoshi K, Matsushita S, Yamane T, Hirose T, Fujihiro S, Endo K, Oka Y, Takeyama K, Kimura T, Uemura T.

J Infect Chemother. 2013 Jun;19(3):393-403. doi: 10.1007/s10156-013-0606-9. Epub 2013 May 3.

6.

The nationwide study of bacterial pathogens associated with urinary tract infections conducted by the Japanese Society of Chemotherapy.

Ishikawa K, Matsumoto T, Yasuda M, Uehara S, Muratani T, Yagisawa M, Sato J, Niki Y, Totsuka K, Sunakawa K, Hanaki H, Hattori R, Terada M, Kozuki T, Maruo A, Morita K, Ogasawara K, Takahashi Y, Matsuda K, Hirose T, Miyao N, Hayashi T, Takeyama K, Kiyota H, Tomita M, Yusu H, Koide H, Kimura S, Yanaoka M, Sato H, Ito T, Deguchi T, Fujimoto Y, Komeda H, Asano Y, Takahashi Y, Ishihara S, Arakawa S, Nakano Y, Tanaka K, Fujisawa M, Matsui T, Fujii A, Yamamoto S, Nojima M, Higuchi Y, Ueda Y, Kanamaru S, Monden K, Tsushima T, Seno Y, Tsugawa M, Takenaka T, Hamasuna R, Fujimoto N, Sho T, Takahashi K, Inatomi H, Takahashi N, Ikei Y, Hayami H, Yamane T, Nakagawa M, Kariya S, Arima T.

J Infect Chemother. 2011 Feb;17(1):126-38. doi: 10.1007/s10156-010-0174-1. Epub 2010 Dec 21.

7.

Single dose 1 g ceftriaxone for urogenital and pharyngeal infection caused by Neisseria gonorrhoeae.

Muratani T, Inatomi H, Ando Y, Kawai S, Akasaka S, Matsumoto T.

Int J Urol. 2008 Sep;15(9):837-42. doi: 10.1111/j.1442-2042.2008.02100.x. Epub 2008 Jul 25.

8.

Glutathione S-transferase (GST) M1, T1 and N-acetyltransferase 2 (NAT2) polymorphisms and urothelial cancer risk with tobacco smoking.

Tsukino H, Nakao H, Kuroda Y, Imai H, Inatomi H, Osada Y, Katoh T.

Eur J Cancer Prev. 2004 Dec;13(6):509-14.

PMID:
15548945
9.

Lack of evidence for the association of E-cadherin gene polymorphism with increased risk or progression of prostate cancer.

Tsukino H, Kuroda Y, Imai H, Nakao H, Qiu D, Komiya Y, Inatomi H, Hamasaki T, Kohshi K, Osada Y, Katoh T.

Urol Int. 2004;72(3):203-7.

PMID:
15084762
10.

Cytochrome P450 (CYP) 1A2, sulfotransferase (SULT) 1A1, and N-acetyltransferase (NAT) 2 polymorphisms and susceptibility to urothelial cancer.

Tsukino H, Kuroda Y, Nakao H, Imai H, Inatomi H, Osada Y, Katoh T.

J Cancer Res Clin Oncol. 2004 Feb;130(2):99-106. Epub 2003 Nov 27.

PMID:
14648207
11.

E-cadherin gene polymorphism and risk of urothelial cancer.

Tsukino H, Kuroda Y, Nakao H, Imai H, Inatomi H, Kohshi K, Osada Y, Katoh T.

Cancer Lett. 2003 May 30;195(1):53-8.

PMID:
12767511
12.

N-acetyltransferase-2 gene polymorphism as a possible biomarker for prostate cancer in Japanese men.

Hamasaki T, Inatomi H, Katoh T, Aono H, Ikuyama T, Muratani T, Matsumoto T.

Int J Urol. 2003 Mar;10(3):167-73.

13.

[Association of vitamin D receptor gene polymorphism with prostate cancer].

Hamasaki T, Inatomi H, Matsumoto T, Katoh T.

Nihon Rinsho. 2002 Dec;60 Suppl 11:465-8. Japanese. No abstract available.

PMID:
12599620
14.

[Faropenem 300 mg 3 times daily versus levofloxacin 100 mg 3 times daily in the treatment of urinary tract infections in patients with neurogenic bladder and/or benign prostatic hypertrophy].

Muratani T, Iihara K, Nishimura T, Inatomi H, Fujimoto N, Kobayashi T, Yamada Y, Takahashi K, Matsumoto T.

Kansenshogaku Zasshi. 2002 Nov;76(11):928-38. Japanese.

PMID:
12508476
15.

Association of vitamin D receptor gene polymorphism with renal cell carcinoma in Japanese.

Ikuyama T, Hamasaki T, Inatomi H, Katoh T, Muratani T, Matsumoto T.

Endocr J. 2002 Aug;49(4):433-8.

16.

Association of genotypes of carcinogen-activating enzymes, phenol sulfotransferase SULT1A1 (ST1A3) and arylamine N-acetyltransferase NAT2, with urothelial cancer in a Japanese population.

Ozawa S, Katoh T, Inatomi H, Imai H, Kuroda Y, Ichiba M, Ohno Y.

Int J Cancer. 2002 Dec 1;102(4):418-21. Erratum in: Int J Cancer. 2003 May 10;104(6):798.

17.
18.

Genetic polymorphisms ofCYP2A6 andCYP2E1 with tobacco smoking is not associated with risk of urothelial cancer.

Tsukino H, Kuroda Y, Nakao H, Imai H, Osada Y, Inatomi H, Kitagawa K, Kawamoto T, Katoh T.

Environ Health Prev Med. 2002 Jul;7(3):129-31. doi: 10.1265/ehpm.2002.129.

19.

A case of von Hippel-Lindau disease with bilateral pheochromocytoma, renal cell carcinoma, pelvic tumor, spinal hemangioblastoma and primary hyperparathyroidism.

Arao T, Okada Y, Tanikawa T, Inatomi H, Shuin T, Fujihira T, Yamashita H, Tanaka Y.

Endocr J. 2002 Apr;49(2):181-8.

20.
21.

Precursors of 2-acetyl-1-pyrroline, a potent flavor compound of an aromatic rice variety.

Yoshihashi T, Huong NT, Inatomi H.

J Agric Food Chem. 2002 Mar 27;50(7):2001-4.

PMID:
11902947
22.
23.
24.

Outbreak of cefozopran (penicillin, oral cephems, and aztreonam)-resistant Neisseria gonorrhoeae in Japan.

Muratani T, Akasaka S, Kobayashi T, Yamada Y, Inatomi H, Takahashi K, Matsumoto T.

Antimicrob Agents Chemother. 2001 Dec;45(12):3603-6.

25.

Emergence of cephem- and aztreonam-high-resistant Neisseria gonorrhoeae that does not produce beta-lactamase.

Akasaka S, Muratani T, Yamada Y, Inatomi H, Takahashi K, Matsumoto T.

J Infect Chemother. 2001 Mar;7(1):49-50.

PMID:
11406757
27.

Diagnosis of retrovesical ectopic and hyperplastic prostate tissue by transrectal needle biopsy.

Hamasaki T, Akasaka S, Yamaguchi R, Inatomi H, Takahashi K, Matsumoto T, Okamoto S.

Urol Int. 2001;66(3):171-3. Review.

PMID:
11316985
29.

Schizophrenia and bladder stones.

Terao T, Nakamura J, Inatomi H, Eto A.

Aust N Z J Psychiatry. 1999 Oct;33(5):769-70. No abstract available.

PMID:
10545010
30.

NAT2 gene polymorphism as a possible marker for susceptibility to bladder cancer in Japanese.

Inatomi H, Katoh T, Kawamoto T, Matsumoto T.

Int J Urol. 1999 Sep;6(9):446-54. Erratum in: Int J Urol 1999 Nov;6(11):592.

31.

Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) genes and risk of urothelial transitional cell carcinoma among Japanese.

Katoh T, Inatomi H, Yang M, Kawamoto T, Matsumoto T, Bell DA.

Pharmacogenetics. 1999 Jun;9(3):401-4. No abstract available.

PMID:
10471074
32.

Results of conservative treatment of upper urinary tract transitional cell carcinoma.

Fujimoto N, Sato H, Mizokami A, Inatomi H, Matsumoto T.

Int J Urol. 1999 Aug;6(8):381-7.

33.

Effects of glutathione S-transferase (GST) M1 and GSTT1 genotypes on urothelial cancer risk.

Katoh T, Inatomi H, Kim H, Yang M, Matsumoto T, Kawamoto T.

Cancer Lett. 1998 Oct 23;132(1-2):147-52.

PMID:
10397466
34.

Human glutathione S-transferase P1 polymorphism and susceptibility to smoking related epithelial cancer; oral, lung, gastric, colorectal and urothelial cancer.

Katoh T, Kaneko S, Takasawa S, Nagata N, Inatomi H, Ikemura K, Itoh H, Matsumoto T, Kawamoto T, Bell DA.

Pharmacogenetics. 1999 Apr;9(2):165-9.

PMID:
10376763
35.

Inhibition by guanidino compounds of the growth of spontaneous mammary tumours in SHN mice.

Tsunoda S, Kawamoto H, Inatomi H, Yamamoto K, Nagasawa H.

Anticancer Res. 1997 Sep-Oct;17(5A):3349-53.

PMID:
9413171
36.
38.

[Clinical study of occupational uroepithelial cancer].

Hamasaki T, Aramaki K, Hida T, Inatomi H, Fujimoto N, Okamura T, Ozu K, Sugita A.

J UOEH. 1996 Dec 1;18(4):247-59. Japanese.

PMID:
8981648
39.
40.

A case of prostate carcinoma metastasizing to renal cell carcinoma.

Inatomi H, Yamada Y, Okamura T.

Int J Urol. 1996 Mar;3(2):155-7.

41.

Suppression by coffee cherry of the growth of spontaneous mammary tumours in SHN mice.

Nagasawa H, Yasuda M, Sakamoto S, Inatomi H.

Anticancer Res. 1996 Jan-Feb;16(1):151-3.

PMID:
8615601
42.

Primary adrenal ganglioneuroblastoma in an adult.

Hiroshige K, Sonoda S, Fujita M, Takasugi M, Kuroiwa A, Inatomi H.

Intern Med. 1995 Dec;34(12):1168-73.

43.
44.

Protection by coffee cherry against spontaneous mammary tumour development in mice.

Nagasawa H, Yasuda M, Sakamoto S, Inatomi H.

Anticancer Res. 1995 Jan-Feb;15(1):141-6.

PMID:
7733624
45.

Improvement by guan-mu-tong (Caulis aristolochiae manshuriensis) of lactation in mice.

Wu G, Yamamoto K, Mori T, Inatomi H, Nagasawa H.

Am J Chin Med. 1995;23(2):159-65.

PMID:
7572777
46.
47.

1H-NMR spectroscopy of urinary components of SHN mice in the course of spontaneous mammary tumourigenesis.

Nagasawa H, Fujii Y, Nishiyama H, Goto Y, Inatomi H.

Anticancer Res. 1992 May-Jun;12(3):993-5.

PMID:
1622158
48.

[Thermal distribution in the agar phantom by a new intracavitary RF applicator for prostate gland].

Inatomi H, Sugita A, Terashima H, Yoshiura T, Kunugita N, Norimura T, Tsuchiya T.

J UOEH. 1992 Mar 1;14(1):39-45. Japanese.

PMID:
1509211
49.
50.

[Chemosensitivity test by subrenal capsule assay (SRCA) in transitional cell carcinomas].

Fujimoto N, Ozu K, Kido K, Inatomi H, Sugita A.

J UOEH. 1991 Dec 1;13(4):279-83. Japanese.

PMID:
1754739

Supplemental Content

Loading ...
Support Center